RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: May 24, 2016

Total Value ($000): $307,386

Holdings (38)

ALNY Alnylam Pharmaceuticals Inc 17.6%
Value ($000) $53,976 Shares 573,361 Est. Cost $99.43 Unrealized -6.8%
La Jolla Pharmaceutical Co 9.5%
Value ($000) $29,279 Shares 1,084,416 Est. Cost $25.34 Unrealized
OMER Omeros Corp 9.3%
Value ($000) $28,618 Shares 1,819,341 Est. Cost $14.29 Unrealized -3.3%
Kite Pharma Inc 8.4%
Value ($000) $25,815 Shares 418,935 Est. Cost $58.27 Unrealized
Dicerna Pharmaceuticals Inc 7.8%
Value ($000) $23,890 Shares 2,012,662 Est. Cost $13.12 Unrealized
Achillion Pharmaceuticals Inc 7.0%
Value ($000) $21,460 Shares 1,988,914 Est. Cost $10.93 Unrealized
BCRX BioCryst Pharmaceuticals Inc 6.7%
Value ($000) $20,748 Shares 2,010,501 Est. Cost $11.05 Unrealized -10.0%
Mirati Therapeutics Inc 4.0%
Value ($000) $12,180 Shares 385,456 Est. Cost $34.42 Unrealized
Atara Biotherapeutics Inc. 3.7%
Value ($000) $11,460 Shares 433,923 Est. Cost $26.41 Unrealized
Five Prime Therapeutics Inc 3.5%
Value ($000) $10,675 Shares 257,236 Est. Cost $22.81 Unrealized
Agenus Inc 3.3%
Value ($000) $10,054 Shares 2,214,453 Est. Cost $8.33 Unrealized
Celldex Therapeutics Inc 3.3%
Value ($000) $9,992 Shares 637,238 Est. Cost $20.17 Unrealized
Symmetry Surgical Inc 2.6%
Value ($000) $8,093 Shares 879,623 Est. Cost $8.78 Unrealized
BMY Bristol-Myers Squibb Co 2.5%
Value ($000) $7,546 Shares 109,701 Est. Cost $45.99 Unrealized +1.5%
Corium International Inc 2.0%
Value ($000) $6,040 Shares 743,865 Est. Cost $11.14 Unrealized
Global Blood Therapeutics Inc 1.8%
Value ($000) $5,663 Shares 175,156 Est. Cost $37.52 Unrealized
Dyax Corp 1.4%
Value ($000) $4,356 Shares 115,795 Est. Cost $14.06 Unrealized
RGNX Regenxbio Inc 1.2%
Value ($000) $3,674 Shares 221,326 Est. Cost $25.09 Unrealized -20.9%
Lipocine Inc 0.9%
Value ($000) $2,851 Shares 220,515 Est. Cost $5.63 Unrealized
Accelerate Diagnostics Inc 0.8%
Value ($000) $2,309 Shares 107,467 Est. Cost $21.49 Unrealized
Invuity Inc 0.6%
Value ($000) $1,789 Shares 202,808 Est. Cost $13.39 Unrealized
CytRx Corp 0.4%
Value ($000) $1,247 Shares 470,576 Est. Cost $2.73 Unrealized
MASI Masimo Corp 0.3%
Value ($000) $1,075 Shares 25,900 Est. Cost $40.86 Unrealized -0.0%
ANIK Anika Therapeutics Inc 0.3%
Value ($000) $1,049 Shares 27,500 Est. Cost $38.25 Unrealized 0.0%
MDRX Allscripts Healthcare Solutions Inc 0.2%
Value ($000) $738 Shares 48,000 Est. Cost $13.76 Unrealized +4.2%
Biopharmx Corp 0.2%
Value ($000) $563 Shares 370,636 Est. Cost $2.56 Unrealized
Genomic Health Inc 0.2%
Value ($000) $528 Shares 15,000 Est. Cost $21.13 Unrealized
NTRA Natera Inc 0.1%
Value ($000) $342 Shares 31,693 Est. Cost $16.90 Unrealized -43.7%
bluebird bio Inc 0.1%
Value ($000) $340 Shares 5,300 Est. Cost $111.52 Unrealized
Nivalis Therapeutics Inc 0.1%
Value ($000) $232 Shares 30,000 Est. Cost $15.17 Unrealized
T2 Biosystems Inc. Cmn 0.1%
Value ($000) $229 Shares 20,900 Est. Cost $10.96 Unrealized
VCYT Veracyte Inc 0.1%
Value ($000) $180 Shares 25,000 Est. Cost $9.52 Unrealized -29.3%
Endologix Inc 0.0%
Value ($000) $149 Shares 15,000 Est. Cost $12.27 Unrealized
VIVO 01/15/2016 CALL 20 0.0%
Value ($000) $110 Shares 1,252 Est. Cost Unrealized
ADAPY Adaptimmune Therapeutics-adr 0.0%
Value ($000) $85 Shares 7,055 Est. Cost $18.35 Unrealized
NVRO 05/20/2016 PUT 50 0.0%
Value ($000) $37 Shares 142 Est. Cost Unrealized
BRK/B Berkshire Hathaway Inc 0.0%
Value ($000) $7 Shares 50 Est. Cost $134.20 Unrealized 0.0%
USO 01/15/2016 CALL 25 0.0%
Value ($000) $7 Shares 13,850 Est. Cost Unrealized